The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

SUMMARY. Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C virus (HCV) will become a reality in the near future. In replacing interferon-based therapies, all-oral regimens are expected to be more tolerable, more effective, shorter in duration and simpler to administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Afdhal, N H, Zeuzem, S, Schooley, R T, Thomas, D L, Ward, J W, Litwin, A H, Razavi, H, Castera, L, Poynard, T, Muir, A, Mehta, S H, Dee, L, Graham, C, Church, D R, Talal, A H, Sulkowski, M S, Jacobson, I M for the New Paradigm of HCV Therapy Meeting Participants
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886291/
https://www.ncbi.nlm.nih.gov/pubmed/24168254
http://dx.doi.org/10.1111/jvh.12173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886291/
https://www.ncbi.nlm.nih.gov/pubmed/24168254
http://dx.doi.org/10.1111/jvh.12173

Ejemplares similares